AGIOS PHARMACEUTICALS, INC. Insider Trading for July 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for July 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 27 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 31.64 | 5,681 | 179,747 | 89,098 | |
| Jul 27 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 23.10 | 1,319 | 30,469 | 94,779 | |
| Jul 27 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 120.45 | 7,000 | 843,150 | 0 | 7 K to 0 (-100.00 %) |
| Jul 27 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 31.64 | 5,681 | 179,747 | 7,000 | 1.3 K to 7 K (+430.71 %) |
| Jul 27 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 23.10 | 1,319 | 30,469 | 1,319 | 0 to 1.3 K |
| Jul 22 2015 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 31.64 | 5,500 | 174,020 | 301,880 | |
| Jul 22 2015 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 113.87 | 5,500 | 626,285 | 34,070 | 39.6 K to 34.1 K (-13.90 %) |
| Jul 22 2015 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 31.64 | 5,500 | 174,020 | 39,570 | 34.1 K to 39.6 K (+16.14 %) |
| Jul 21 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 23.10 | 1,093 | 25,248 | 96,098 | |
| Jul 21 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 9.05 | 3,725 | 33,711 | 97,191 | |
| Jul 21 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 2.34 | 7,273 | 17,019 | 100,916 | |
| Jul 21 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.69 | 909 | 625 | 108,189 | |
| Jul 21 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 113.71 | 13,000 | 1,478,230 | 0 | 13 K to 0 (-100.00 %) |
| Jul 21 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 23.10 | 1,093 | 25,248 | 13,000 | 11.9 K to 13 K (+9.18 %) |
| Jul 21 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 9.05 | 3,725 | 33,711 | 11,907 | 8.2 K to 11.9 K (+45.53 %) |
| Jul 21 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 2.34 | 7,273 | 17,019 | 8,182 | 909 to 8.2 K (+800.11 %) |
| Jul 21 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.69 | 909 | 625 | 909 | 0 to 909 |
| Jul 17 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 114.20 | 2,426 | 277,049 | 157,558 | 160 K to 157.6 K (-1.52 %) |
| Jul 17 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 114.17 | 2,426 | 276,976 | 157,558 | 160 K to 157.6 K (-1.52 %) |
| Jul 17 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 114.35 | 2,426 | 277,413 | 159,984 | 162.4 K to 160 K (-1.49 %) |
| Jul 17 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 114.38 | 2,426 | 277,486 | 159,984 | 162.4 K to 160 K (-1.49 %) |
| Jul 17 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 11,736 | 3,550 | 315,022 | |
| Jul 17 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 8,264 | 2,500 | 326,758 | |
| Jul 17 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 114.02 | 20,000 | 2,280,400 | 121,835 | 141.8 K to 121.8 K (-14.10 %) |
| Jul 17 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 11,736 | 3,550 | 141,835 | 130.1 K to 141.8 K (+9.02 %) |
| Jul 17 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 8,264 | 2,500 | 130,099 | 121.8 K to 130.1 K (+6.78 %) |
| Jul 08 2015 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 96.32 | 5,500 | 529,760 | 34,070 | 39.6 K to 34.1 K (-13.90 %) |
| Jul 08 2015 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 97.64 | 5,500 | 537,020 | 39,570 | 45.1 K to 39.6 K (-12.20 %) |